<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="develop">
            <roleset id="develop.01" name="" wordnet="10">
                <roles>
                    <role n="0" descr="non-intentional theme&#x0A;" />
                    <role n="1" descr="thing developed&#x0A;" />
                    <role n="2" descr="end result&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son may develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman with whose child develops high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman with whose son develops at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman with whose son develops high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman at risk of developing whose child of acute onset of the development of OTC deficiency at a new RsaI recognition site in exon 6.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman at risk of developing whose son of acute neonatal start of OTC deficiency at a new RsaI recognition site in exon 6.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman at risk of developing whose son of at the start of the OTC deficit in the neonatal period at a new RsaI recognition site in exon 6.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic female carrier whose child can develop acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic female carrier whose child can develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose child is predicted to develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose child is thought to develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son is developing high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son is to develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying son was developing acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying son was observed to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose child has developed acute onset of OTC deficit in the neonatal period.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose child was developing acute onset of OTC deficit in the neonatal period.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son had the ability to develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son has been developing at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son was developing at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son was found to develop at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son was observed to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son was shown to develop acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son would develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>A C-T transition in codon 214 was identified, which created a new RsaI recognition site in exon 6 and which replaced tyrosine with histidine (H214Y), in an asymptomatic woman with son was considered to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>A C-T transition in codon 214 was identified, which created a new RsaI recognition site in exon 6 and which replaced tyrosine with histidine (H214Y), in an asymptomatic woman with whose child was considered to develop acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>A C-T transition in codon 214 was identified, which created a new RsaI recognition site in exon 6 and which replaced tyrosine with histidine (H214Y), in an asymptomatic woman with whose son was considered to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose child risks developing high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son can develop at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son develops acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son may have developed acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son may have developed high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>A C-T transition to codon 214, which develop a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son is considered to have development high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>A0 is planted from September to late October, and can be developed in the pink phase and continues to grow until late November.</text>
                    <arg n="2">the pink phase</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>A0 is planted from September to late October, and can be developed in the rose stage and continues to grow until late November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>A0 is planted from September to the end of October, and it is predicted to become rose phase and develop to grow until the end of November.</text>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>A0 is planted from September to the end of October, and it is predicted to become the rose stage and develop to grow until the end of November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>A0 is planted from September to the end of October, and it is thought to develop in roseta phase and continues to grow until the end of November.</text>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>A0 is planted from September to the end of October, being able to develop roseta phase and continues to grow until the end of November.</text>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>A0 was planted from September to the end of October, and the evolution in the rose stage was observed and continues to develop until the end of November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Although Pin1 -/-mouses had normally developed Fujimori et al., 1999, we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mouses</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>It is believed that October stem will develop roseta phase and grows by the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>It is believed that sown in October has develop the rose phase and grown by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>It is believed that sown in October will develop the rose phase and grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>It is believed that sown of the October will develop roseta and grows by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>It is believed that stem sown in October has develop the rosette phase and grown by the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>It was predicted that the spinal planted in October would develop in the roseta phase phase and grew in late November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>October stem is predicted to become roseta phase and develop until late November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>October stem may develop in roseta phase and increased at the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>October stem that develops in roseta phase grows at the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>October stem was developed in roseta phase and grew at the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>October stem was expected to develop roseta phase and grown towards the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>Spinach planted in October can develop in the rosette stage and grow until late November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>Spinach planted in October develop the rosette stage and grew up to the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>Spinach planted in October developing in the rosette stage grows by the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Spinach planted in October has the ability to develop in the rosette stage and grow by the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Spinach planted in October is predicted to become the rosette stage and develop until late November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Spinach planted in October may develop in the rose stage and grow until the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Spinach planted in October that developing to the rosette stage grows at the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Spinach planted in October was able to develop in the rose stage and grew at the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Spinach planted in October was converted to the rosette stage and may developing by the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Spinach planted in October which is able to develop in the rosette stage grows by the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>The A0 is planted from September to late October, and can be developed to rose phase and continues to grow until late November.</text>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>The A0 is planted from September to late October, and develops in the pink phase and continues to grow until late November.</text>
                    <arg n="2">the pink phase</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>The A0 is planted from September to late October, and develops in the rose stage and continues to grow until late November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>The A0 is planted from September to late October, and is predicted to become the roseta phase and develop to grow until late November.</text>
                    <arg n="2">the roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>The A0 is planted from September to late October, and is thought to develop in rose phase and continues to grow until late November.</text>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>The A0 is planted from September to late October, and is thought to develop in roseta phase and continues to grow until late November.</text>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>The October stem has become roseta phase and has developed until the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>The sown in October has the ability to develop in the pink phase and grow in late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>The sown in October is develop in the pink phase and grows in late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>The sown in October that is able to develop in pink phase grows until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>The sown of the October is develop in the roseta and grows in late November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>The spinal planted in October is develop in the roseta phase and grows in late November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>The spinal planted in October that is able to develop in roseta phase grows until late November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>The stem sown in October has become roseta phase and has developed until the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>The stem sown in October is develop in the the rosette phase and grows in late November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>The stem sown in October that is able to develop in the rosette phase grows until late November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>The transition C-T to codon 214, creating a new SSRI recognition site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son could develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>The transition C-T to codon 214, creating a new SSRI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying son had the ability to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>The transition C-T to codon 214, creating a new SSRI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose child had the ability to develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>The transition C-T to codon 214, creating a new SSRI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son had the ability to develop acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose child can develop acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son can develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son was developing acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son was observed to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son was predicted to develop acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son would develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying son at the risk of developing acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose child at the risk of developing high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>october seed spinel developed in roseta phase and grew at the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>october seed spinel develops roseta phase grows by the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>october seed spinel had the ability to develop in roseta phase and grew up to the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>october seed spinel has the ability to develop in roseta phase and grow by the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>october seed spinel is found to develop in roseta phase and grow until late November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>october seed spinel may develop in roseta phase and grew up to the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>october seed spinel was converted to roseta phase and may developing by the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>october seed spinel was develop to be roseta phase and grew up to the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>october seed spinel was found to have develop roseta phase and grew until late November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>sown in October can develop in pink phase and grow until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>sown in October can develop in the rose phase and grow until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>sown in October developed in the phase of the rosette and grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>sown in October developed in the rose phase and grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>sown in October developed the rose phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>sown in October has the ability to develop in the rose phase and grow by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>sown in October is predicted to become pink phase and develop until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>sown in October is under development for the the rose phase and can developing by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>sown in October may develop in the phase of the rosette and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>sown in October may develop in the phase of the rosette and increased at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>sown in October may develop in the rose phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>sown in October may develop in the rose phase and grow until the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>sown in October that developing to pink phase grows at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>sown in October that develops in the phase of the rosette grows at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>sown in October was develop to be pink phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>sown in October was develop to be the rose phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>sown in October which may develop in the phase of the rosette grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>sown of the October can be developed in the A2 phase (roseta) and increased by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>sown of the October developed in roseta and grew at the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>sown of the October developed in roseta and grows by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>sown of the October developed roseta and grew up to the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>sown of the October may have been developed in roseta and grown by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>sown of the October was develop to be roseta and grew up to the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>sown of the October which may develop in roseta grows by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>spinal planted in October developed in roseta phase and grew at the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>spinal planted in October had the ability to develop in roseta phase and grew up to the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>spinal planted in October is develop for development for rose phase and growth at the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>spinal planted in October may develop in roseta phase and grow by the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>spinal planted in October may develop in roseta phase and increased at the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>spinal planted in October that developing to roseta phase grows at the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>spinal planted in October was found to have develop rose phase and grew until late November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>stem sown in October develop roseta phase and grew up to the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>stem sown in October developed roseta phase and grew up to the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>stem sown in October developing in the rosette phase grows by the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>stem sown in October may develop in roseta phase and grow until the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>stem sown in October was shown to have develop roseta phase and grew until late November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes may develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes will have developed a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman with we develops a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman at risk of developing us of a new screening system at a new RsaI recognition site in exon 6.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman at risk of developing we of a new screening system at a new RsaI recognition site in exon 6.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic female carrier ens can develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic female carrier us can develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying ens is observed to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying ens is thought to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying ens is to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying nodes has the ability to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying nodes is predicted to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying nodes may have developed a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying us is observed to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying us is to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying us may have developed a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying ens was developing a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying ens was predicted to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying nodes could develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying us could develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying us was found to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying us would develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying we could develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying we had the ability to develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying we was observed to develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying we would develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>A C-T transition in codon 214 was identified, which created a new RsaI recognition site in exon 6 and which replaced tyrosine with histidine (H214Y), in an asymptomatic woman with we was considered to develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier ens risks developing a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes can develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes has developed a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes is developing a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier us has the ability to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier us is able to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier us is developing a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier us may have developed a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>A C-T transition to codon 214, which develop a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier ens is considered to have development a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Although Pin1 -/-mouse develops usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Although Pin1 -/-myce can develop usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">myce</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Although Pin1 -/-nodes can develop usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">nodes</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Although Pin1 -/-nodes develops usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">nodes</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Although Pin1 -/-nodes has previously shown to develop usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">nodes</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>Although Pin1 -/-us had normally developed Fujimori et al., 1999, we did not find a variety of cellular proliferative abnomalies, including reduced body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">us</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>Although Pin1 -/-we had normally developed Fujimori et al., 1999, we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">we</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>The transition C-T to codon 214, creating a new SSRI recognition site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying we could develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>The transition C-T to codon 214, creating a new SSRI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying us had the ability to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier nodes was developing a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier us was developing a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier us was observed to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier us was predicted to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier we had developed a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying nodes at the risk of developing a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying we at the risk of developing a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
